The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword

Objective Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) was first detected in Wuhan, China in December, 2019. The emerging virus causes a respiratory illness, that can trigger a cytokine storm in the body. Method Cytokine storm in patient’s body is associated with severe forms of disea...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2022-01, Vol.49 (1), p.605-615
Main Authors: Heydarian, Mohammad, Mohammadtaghizadeh, Mohammadjavad, Shojaei, Mahboobeh, Babazadeh, Marziyeh, Abbasian, Sadegh, Amrovani, Mehran
Format: Article
Language:English
Subjects:
Animal Anatomy
Animal Biochemistry
Antineoplastic Agents - therapeutic use
Biomedical and Life Sciences
Cancer
Cancer therapies
Chemotherapy
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - immunology
Cytokine Release Syndrome
Cytokine storm
Drug Resistance
Histology
Humans
Life Sciences
Morphology
Neoplasms - drug therapy
Patients
Review
SARS-CoV-2 - immunology
Severe acute respiratory syndrome coronavirus 2
Tumor cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) was first detected in Wuhan, China in December, 2019. The emerging virus causes a respiratory illness, that can trigger a cytokine storm in the body. Method Cytokine storm in patient’s body is associated with severe forms of disease. It is one of the main complications of coronavirus disease-2019 (COVID-19), in which immune cells play a major role. Studies have shown immune cells in the tumor environment can be effective to induce resistance to chemotherapy in cancer patients. Result Therefore, considering the role of immune cells to induce cytokine storm in COVID-19 patients, and their role to cause resistance to chemotherapy, they are effective on disease progression and creation of severe form of disease. Conclusion By examining the signaling pathways and inducing resistance to chemotherapy in tumor cells and the cells affect them, it is possible to prevent the occurrence of severe forms of the disease in cancer patients with COVID-19; it is applicable using target therapy and other subsequent treatment strategies.
ISSN:0301-4851
1573-4978
1573-4978
DOI:10.1007/s11033-021-06800-4